Comerica Inc (CMA)

CMA (NYSE:Banking) EQUITY
$40.02
pos +0.00
+0.00%
Today's Range: 40.01 - 42.09 | CMA Avg Daily Volume: 2,595,000
Last Update: 06/24/16 - 4:03 PM EDT
Volume: 0
YTD Performance: -4.33%
Open: $0.00
Previous Close: $44.48
52 Week Range: $30.48 - $53.45
Oustanding Shares: 175,133,972
Market Cap: 7,789,959,075
6-Month Chart
TheStreet Ratings Grade for CMA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 3 3 2 2
Hold 11 11 13 11
Moderate Sell 0 0 0 1
Strong Sell 2 2 1 1
Mean Rec. 2.83 2.83 2.78 2.82
Latest Dividend: 0.22
Latest Dividend Yield: 1.98%
Dividend Ex-Date: 06/13/16
Price Earnings Ratio: 18.16
Price Earnings Comparisons:
CMA Sector Avg. S&P 500
18.16 18.20 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.20% -23.99% 4.11%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.30 0.10 0.02
Net Income -12.10 0.00 0.00
EPS -10.10 0.10 0.03
Earnings for CMA:
EBITDA 0.97B
Revenue 2.83B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.68 $0.73 $2.52 $3.22
Number of Analysts 13 11 15 15
High Estimate $0.72 $0.78 $2.65 $3.60
Low Estimate $0.60 $0.69 $2.40 $2.90
Prior Year $0.73 $0.74 $2.92 $2.52
Growth Rate (Year over Year) -7.06% -1.23% -13.79% 28.02%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

bullishComerica upgraded at Goldman

May 19, 2016 | 7:12 AM EDT

CMA was upgraded from Sell to Neutral, Goldman Sachs said. $49 price target. Company can restructure or possibly sell the business. 

By

Tim Melvin

 | May 13, 2016 | 1:00 PM EDT

I am keeping my eye on the bank specialists and activists as 13F filings start rolling in.

bullishComerica upgraded at BofA/Merrill

Apr 21, 2016 | 7:26 AM EDT

CMA was upgraded from Underperform to Neutral, Bank of America/Merrill Lynch said. $45 price target. Strategic review should support the stock. 

By

Doug Kass

 | Apr 19, 2016 | 3:46 PM EDT
The U.S. dollar weakened. Crude oil rose by $1.22 to $41.00. Nat gas was up by sixteen cents. Gold rose by $18.70 to $1,253. Silver was up by 70 cents. More upside action in agricultural chemicals, with Potash (POT) up $1.20. Wheat +11.50, corn +3.50, soybeans +28.50 and oats +5.25. Lumber was +6.40. Bonds dropped a bit in price, and were slightly higher in yield. The 10-year U.S. note yield rose by one basis point to 1.78% and the long bond by a similar amount and yields 2.59%. Municipals down slightly; closed-end muni funds' rapid advance dissipated late in the day ... finally! High yield was well-bid. iShares iBoxx High Yield Corporate Bond ETF (HYG) was up 36 cents and SPDR Barclays High Yield Bond ETF (JNK) was up 15 cents. Blackstone/GSO Strategic Credit Fund (BGB) was three cents lower; I am out of the name now. Banks exploded to the upside, led by JPMorgan Chase (JPM), Wells Fargo (WFC) and Comerica (CMA), all up by over a beaner. Life insurance advanced again, though my long Hartford Financial Services Group (HIG) lagged. Brokerages were up, led by Morgan Stanley (MS), up 64 cents, and Goldman Sachs (GS), up $3.65. Retail was quiet. Home Depot (HD) was a downside leader, off $1.50. Lowe's (LOW) was weak, too. Old tech got IBM'd, with IBM (IBM) down $8.50. Staples were broadly higher, led by long Procter & Gamble (PG), up 50 cents. Old media was mixed. Comcast (CMCSA) was lower but Disney (DIS) led the parade. Autos were strong, continuing the Barron's push over the past weekend. Ford (F) was up 15 cents and General Motors (GM) up 65 cents. Oils responded to better commodity pricing. Schlumberger (SLB) was the league leader, up $1.70. Biotech and the rest of the Nasdaq were conspicuously to the downside. iShares Nasdaq Biotechnology ETF (IBB) was down 1.66%. Allergan (AGN) is still recovering (up $4.50) and my former biotech basket got hit, but not materially so. (T)FANG weakness was also obvious, though Facebook (FB) had a late-day kick save. NOSH was mixed. So was CRABBY. In individual stocks, Twitter (TWTR) was a poor actor. On the other hand, fav long DuPont (DD) was strong, up $1.15. Here are some great posts on RealMoneyPro today: Some oil vey from Jim "El Capitan" Cramer.  Tim "Not Phil or Judy" Collins on some overnight trade ideas.  And also from Tim, some SPY-ing.  RevShark on
By

Tim Melvin

 | Apr 13, 2016 | 2:00 PM EDT

These underpriced stocks have averaged 17% annual returns since 1999.

By

Doug Kass

 | Mar 21, 2016 | 12:03 PM EDT
Bank of America (BAC): $14.00 BB&T Corp. (BBT): $34.90 Citigroup (C): $44.10 Comerica (CMA): $39.75
By

Doug Kass

 | Mar 3, 2016 | 2:59 PM EST
The U.S. dollar weakened today. Government bonds dropped by two to three basis points in yield. The 10-year yields 1.83% and the long bond 2.66%. Municipals were flat, as was high yield. Blackstone/GSO Strategic Credit Fund (BGB) was up a few pennies. Crude oil rose by two cents to $34.68. Nat gas was two cents lower. In agricultural commodities, wheat rose by 8.50 and oats 7.00, but soybeans were only up 2.00 Corn was flat. Shares of Potash (POT) recently have benefited from higher ag prices. Gold ramped to $1,258, up $16.40). Silver was up 15 cents. Financials were firm, and bank stocks slightly higher (I reduced positions yesterday). Comerica (CMA) looks to be breaking out from its trading range, up $1.25 today. Life insurance stocks were well-bid. I shorted MetLife (MET) and Lincoln National (LNC) yesterday. Brokerages were stronger, led by long holding Goldman Sachs (GS). Morgan Stanley (MS) was flat. Old tech was mixed, with IBM (IBM) up and Microsoft (MSFT) down. Biotech returned to underperformance today, with Valeant Pharmaceuticals (VRX) and Allergan (AGN) very weak. I sold my entire Biotech Basket yesterday for a nice gain. In the basket, Aerie Pharmaceuticals (AERI), down 17%, and Celgene (CELG), down $1.71, led on downside while Interxon (XON) continued to gain after yesterday's outsize move higher. Retail was broadly higher; Best Ideas List stock Bed, Bath & Beyond (BBBY) was up almost 3%. Macy's (M) is back near its high and Best Buy (BBY) was trending higher as well. Media is well-bid. My shorts Comcast (CMCSA) and Disney (DIS) are higher. Consumer staples were mixed; Procter & Gamble (PG) was higher but Kimberly-Clark (KMB) lower. Autos are strong today, with Ford (F) up 25 cents and General Motors (GM) up 80 cents. (T)FANG might be flailing. Only Tesla (TSLA) is up on the day, but the losses have been contained. NOSH lower, led by Nike (NKE) to the downside. CRABBY was well-bid, with only Alleghany (Y) lower. Twitter (TWTR) continues its rise from sub-$14; it's now over $19. Starbucks (SBUX), a short, is off 70 cents. Blackstone Group (BX), though slightly lower, is holding on to its nice recent gains.  I re-shorted SLB and XOM and placed these energy names on my Best Ideas List as shorts. I sold Allstate (ALL) after a $9 move up from the market's recent lows.  I have increased my net short exposure today.
By

Doug Kass

 | Mar 2, 2016 | 1:13 PM EST
Reduced my bank longs across the board. Sold off my
By

Doug Kass

 | Mar 1, 2016 | 11:41 AM EST
Banks. I'm long on Citigroup (C), Bank of America (BAC), JPMorgan Chase (JPM), Wells Fargo (WFC), Comerica (CMA), Fifth Third Bancorp (FITB), Southern National Bancorp of Virginia (SONA), Regions Financial (RF) and BB&T (BBT). I wouldn't chase these stocks here, but would buy on dips as a multi-year upside play. Brokerages. I currently own Morgan Stanley (MS) and Goldman Sachs (GS). These stocks are dirt cheap relative to their earnings power and tangible book v
By

Doug Kass

 | Feb 29, 2016 | 12:55 PM EST
The yield curve has collapsed to its flattest level since November 2007.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.